Litigation Details for Kaneka Corporation v. Xiamen Kingdomway (Fed. Cir. 2014)
✉ Email this page to a colleague
Kaneka Corporation v. Xiamen Kingdomway (Fed. Cir. 2014)
Docket | ⤷ Try a Trial | Date Filed | 2014-03-24 |
Court | Court of Appeals for the Federal Circuit | Date Terminated | |
Cause | Assigned To | ||
Jury Demand | Referred To | ||
Patents | 10,500,249 | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Kaneka Corporation v. Xiamen Kingdomway
Details for Kaneka Corporation v. Xiamen Kingdomway (Fed. Cir. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2014-08-06 | 50 | into the U.S. national stage as Application No. 10/500,249 (the “first U.S. application”). (A12465-12912…. ‘340 Patent Prosecution History U.S. Patent No. 7,910,340 (“the ’340 patent”) is titled …Merck is summarized in U.S. Patent No. 3,066,080 (“Folkers” or “the Merck patent”), which issued in 1962…/2014 Japanese Patent Application 2001-398545, filed December 27, 2001. A Patent Cooperation Treaty…the ‘340 patent is largely directed to producing reduced CoQ10. (A64-81). The ‘340 patent’s disclosure | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |